PNC Financial Services Group
AVNR

PNC Financial Services Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

PNC Financial Services Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-71,373
Closed -$1.21M – 4880
2014
Q4 		$1.21M Buy
71,373
+61,882
+652% +$871K ﹤0.01% 1118
2014
Q3 		$114K Buy
9,491
+9,000
+1,833% +$61.5K ﹤0.01% 2317
2014
Q2 		$3K Hold
491
– – ﹤0.01% 3480
2014
Q1 		$2K Buy
+491
New +$1.87K ﹤0.01% 3611

PNC Financial Services Group's AVNR Position: Q1 2015 in Review

PNC Financial Services Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 71,373 shares — an estimated $1.21M sold.

PNC Financial Services Group first reported a position in AVNR in Q1 2014 and held it in 4 quarters. The position peaked at $1.21M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • PNC Financial Services Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 71,373 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.21M.
  • PNC Financial Services Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q1 2014 and held it in 4 quarters.
  • PNC Financial Services Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.21M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on PNC Financial Services Group's 13F filing for Q1 2015, filed 8 May 2015.